Chronic hepatitis C virus is the most common cause of liver disease, about 300 million people worldwide. The virus has been seen in the Japanese population decades before the United States, with the result that HCV patients are 10 to 15 years older than patients in the Western countries in Japan. The standard treatment is a combination therapy with interferon or pegylated interferon and the antiviral drug ribavirin. However, this treatmentnt tends with adverse effects dose reduction or dose reduction or discontinuation of therapy in up to 28 % of patients assigned to either.
Luke Griggs, spokesman for Headway, said: ‘We welcome the recent decision by the Defense Ministry, serving a wide survey of possible brain damage by in Iraq and Afghanistan in Iraq and Afghanistan carry taken there is a clear trend in the U.S., the increased rates of head. And brain injuries in soldiers returning home and this urgently needs to study in British troops. » Read the rest of this entry «